Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
digital therapeutics
MedTech
Meet Motivista: Click's new schizophrenia digital therapeutic
Click has nabbed FDA approval for its digital therapeutic Motivista, now the first authorized treatment for negative schizophrenia symptoms.
Ben Adams
Oct 5, 2026 6:00am
Merck KGaA, Remepy team up on hybrid drugs for rare tumors
Apr 28, 2026 7:00am
MindMaze seeks 'strategic alternatives,' eyes US expansion
Mar 3, 2026 9:25am
FDA clears Lumosity brain training games for adult ADHD
Dec 11, 2025 10:00am
Boehringer, Click DTx hits phase 3 goal in schizophrenia
Oct 14, 2025 12:08pm
FDA clears prescription migraine app from Click Therapeutics
Apr 17, 2025 11:35am
